Page last updated: 2024-09-05

sb 203580 and 2',4',6'-tris(methoxymethoxy) chalcone

sb 203580 has been researched along with 2',4',6'-tris(methoxymethoxy) chalcone in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(2',4',6'-tris(methoxymethoxy) chalcone)
Trials
(2',4',6'-tris(methoxymethoxy) chalcone)
Recent Studies (post-2010) (2',4',6'-tris(methoxymethoxy) chalcone)
3,48941,1371006

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jin, XY; Kim, HD; Kim, JY; Lee, SH; Seo, GS; Sohn, DH1

Other Studies

1 other study(ies) available for sb 203580 and 2',4',6'-tris(methoxymethoxy) chalcone

ArticleYear
Heme oxygenase 1 mediates anti-inflammatory effects of 2',4',6'-tris(methoxymethoxy) chalcone.
    European journal of pharmacology, 2006, Feb-17, Volume: 532, Issue:1-2

    Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Blotting, Northern; Blotting, Western; Cell Line; Chalcones; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Gene Expression; Glutathione; Heme Oxygenase-1; Imidazoles; Intracellular Fluid; Lipopolysaccharides; Macrophage Activation; Macrophages; Mitogen-Activated Protein Kinases; Molecular Structure; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Pyridines; Reactive Oxygen Species; RNA, Messenger

2006